Polymyxin B Therapy-Induced Respiratory Arrest in a Liver Donor: A Case Report

Polymyxin B is a potent antibiotic used in multi-drug resistant (MDR) gram-negative infections. It is a known nephrotoxic and neurotoxic drug with serious side effects. Respiratory paralysis is very rarely seen with polymyxin B therapy, with only a few cases reported worldwide. We report a case of a young liver donor who developed respiratory arrest after receiving intravenous (IV) polymyxin B, required intubation, and mechanical ventilatory support. The patient regained full consciousness within an hour. After reviewing literature, we found that polymyxins can cause such side effects. Polymyxin B was discontinued, and she was extubated the following day. With the emergence of MDR organisms, the use of polymyxin B has increased tremendously. This case highlights the importance of closely monitoring patients who are administered such potent antibiotics

Authors

Publication Details

Published
2025-06-06
DOI
https://doi.org/10.62830/mmj2-02-14c
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Polymyxin B Therapy-Induced Respiratory Arrest in a Liver Donor: A Case Report

D Navakanth
Antibiotic Resistance in Bacteria
article

Polymyxin B Therapy-Induced Respiratory Arrest in a Liver Donor: A Case Report

D Navakanth
article en

Abstract

Polymyxin B is a potent antibiotic used in multi-drug resistant (MDR) gram-negative infections. It is a known nephrotoxic and neurotoxic drug with serious side effects. Respiratory paralysis is very rarely seen with polymyxin B therapy, with only a few cases reported worldwide. We report a case of a young liver donor who developed respiratory arrest after receiving intravenous (IV) polymyxin B, required intubation, and mechanical ventilatory support. The patient regained full consciousness within an hour. After reviewing literature, we found that polymyxins can cause such side effects. Polymyxin B was discontinued, and she was extubated the following day. With the emergence of MDR organisms, the use of polymyxin B has increased tremendously. This case highlights the importance of closely monitoring patients who are administered such potent antibiotics

Openalex Percentile: Top 90%
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.